Induction therapy for poor-prognosis anal canal carcinoma: a phase II study of the Cancer and Leukemia Group B (CALGB 9281).
- Citation:
- J Clin Oncol vol 26 (19) 3229-34
- Year:
- 2008
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- 797
- Children:
- None
- Pharmas:
- Grants:
- CA33601, CA32291, CA03927, CA35421, CA04326, CA47559, CA31946
- Corr. Author:
- Authors:
- Neal J Meropol Donna Niedzwiecki Brenda Shank Thomas A Colacchio John Ellerton Frank Valone Susan Budinger Jeannette M Day Judy Hopkins Joel Tepper Richard M Goldberg Robert J Mayer
- Networks:
- Study
- CALGB-9281
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Anus Neoplasms, Carcinoma, Squamous Cell, Chemotherapy, Adjuvant, Cisplatin, Combined Modality Therapy, Female, Fluorouracil, Humans, Male, Middle Aged, Mitomycin, Neoadjuvant Therapy, Prognosis, Prospective Studies, Survival Rate, Treatment Outcome